methoxy polyethylene glycol-epoetin beta [Mircera]
methoxy polyethylene glycol-epoetin beta [Mircera] is a pharmaceutical drug with 31 clinical trials. Historical success rate of 87.1%.
Success Metrics
Based on 27 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
27
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.1%
27 of 31 finished
12.9%
4 ended early
0
trials recruiting
31
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.
A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic Nephropathy
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
Clinical Trials (31)
A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.
A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic Nephropathy
A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.
A Study of Once Monthly Intravenous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.
A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia
A Study of Once Monthly Subcutaneous Mircera in Patients With Chronic Renal Anemia Not on Dialysis
A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia
A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis Patients
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.
A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
A Study of Mircera for the Treatment of Anemia in Dialysis Patients
A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.
A Study Comparing Maintenance of Hemoglobin Levels, Safety and Tolerability of Once Every 4 Weeks Mircera Versus Epoetin Beta in Dialysis Patients With Chronic Renal Anemia.
A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
A Study of Once Monthly Subcutaneous Mircera in Dialysis Patients With Chronic Renal Anemia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 31